Signal #144084 · SEC 8-K

$TRDA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $TRDA filing catalyst

Why did $TRDA trigger an AI stock catalyst alert?

$TRDA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Entrada Therapeutics Reports Q3 Net Loss of $39.7M, Cash Runway Extended into Q4 2027. Key points: - Q3 2026 collaboration revenue declined to $0.9M vs. $1.6M in Q3 2025; net loss narrowed to $39.7M ($0.94/share) from $44.1M. - Cash, cash equivalents and marketable securities stood at $193.0M at quarter-end, down from $295.7M at year-end 2025. - ELEVATE-44-201 Cohort 1 data expected by year-end 2026; cash runway projected into Q4 2027.

How did $TRDA stock react after the SEC filing?

After the SEC 8-K for $TRDA, observed market reaction: T0 price $5.06. Past moves do not guarantee future results.

Where can I get real-time $TRDA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $TRDA via Telegram and the VIP Web Terminal from €10/month.

$TRDA

$TRDA – Entrada Therapeutics Reports Q3 Net Loss of $39.7M, Cash Runway Extended into Q4 2027

Entrada Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $TRDA

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 2026 collaboration revenue declined to $0.9M vs. $1.6M in Q3 2025; net loss narrowed to $39.7M ($0.94/share) from $44.1M.
Cash, cash equivalents and marketable securities stood at $193.0M at quarter-end, down from $295.7M at year-end 2025.
ELEVATE-44-201 Cohort 1 data expected by year-end 2026; cash runway projected into Q4 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →